TE_22
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | MLT1B |
---|---|
TE superfamily | MaLR |
TE class | LTR |
Gene | - |
Class | Intergenic |
Coding | Non-coding, Other |
Tumor-specific score | 3.17 |
Counts of samples | TCGA_tumor:1466; TCGA_normal:154; GTEx:367 |
TSS | chr1(-):1132948 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_22.11 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123671,1123691,1123770,1127432,1128491,1131892,1132905,1132949 |
teRNA_22.12 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123695,1123715,1123782,1124052,1124103,1127432,1128491,1131892,1132905,1132949 |
teRNA_22.13 | - | Intergenic | Non-coding | Non-coding | chr1(-):1127412,1127432,1129358,1131892,1132905,1132949 |
teRNA_22.14 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123975,1123995,1124139,1127432,1128491,1131892,1132905,1132949 |
teRNA_22.15 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123494,1123514,1123595,1123715,1124115,1127432,1128491,1131892,1132905,1132949 |
teRNA_22.16 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123494,1123514,1123581,1127432,1128491,1131892,1132905,1132949 |
teRNA_22.17 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123954,1123974,1124030,1124114,1124139,1127432,1128491,1131892,1132905,1132949 |
teRNA_22.18 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123097,1123117,1123503,1127432,1128491,1131892,1132905,1132949 |
teRNA_22.19 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1127412,1127432,1128491,1130017,1131649,1131892,1132905,1132949 |
teRNA_22.20 | - | Intergenic | Other | MLTSITVSVSLDFPIPGPRRVQLPYTATAFCPSVAWPCVAQCRGSLSVSEAEGRLVPHSLCASQAALMLCAPNLCRTGFRPGQRRLCPHPRCSQCPRTLSTGINLVSLQELSARKCKSWLLSLSPPLRAPWLGHSQAPRNSGAFAAIFSYRNPQTPIIITGTQDPSFSRGAHGHPVAPSRHLRSGCGTPGPAHLASTALQAPADPHHPPANSRSRQPWGRPSG* | chr1(-):1123494,1123514,1123595,1127432,1128491,1131892,1132905,1132949 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.